User login
Alevicyn SG Antipruritic Spray Gel
IntraDerm Pharmaceuticals, a division of Oculus Innovative Sciences, Inc, receives 510(k) clearance from the US Food and Drug Administration for Alevicyn SG Antipruritic Spray Gel with both prescription and over-the-counter indications. The Alevicyn SG prescription product manages and relieves the burning, itching, and pain experienced with dermatoses such as radiation dermatitis and atopic dermatitis. It also relieves the pain of first- and second-degree burns and helps to relieve dry waxy skin by maintaining a moist wound environment, which is beneficial to the healing process. The over-the-counter product relieves the burning and itching associated with many common types of skin irritation, lacerations, abrasions, and minor burns including sunburn. For more information, visit www.intraderm.com.
Promius Promise
Promius Pharma LLC announces that the Promius Promise program has been expanded to include Cloderm (clocortolone pivalate) Cream 0.1% and Trianex (triamcinolone acetonide) Ointment 0.05%, both for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. The Promius Promise program was created in 2013 to support patients. This program features a dedicated call center staff to educate patients about their insurance coverage and answer any questions they may have about their out-of-pocket cost, co-pay assistance, and prior authorizations. For more information, visit www.promiuspharma.com.
Radiesse
Merz North America, Inc, receives US Food and Drug Administration approval of Radiesse for correction of volume loss in the dorsum of the hands. Radiesse is an opaque dermal filler composed of calcium hydroxylapatite microspheres suspended in a water-based gel carrier. It provides an immediate volumizing effect and helps reduce the prominence of tendons and veins in the hands, delivering natural-looking results that can last up to 1 year. Radiesse also is indicated for subdermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. For more information, visit www.MerzUSA.com.
If you would like your product included in Product News, please e-mail a press release to the Editorial Office at cutis@frontlinemedcom.com.
Alevicyn SG Antipruritic Spray Gel
IntraDerm Pharmaceuticals, a division of Oculus Innovative Sciences, Inc, receives 510(k) clearance from the US Food and Drug Administration for Alevicyn SG Antipruritic Spray Gel with both prescription and over-the-counter indications. The Alevicyn SG prescription product manages and relieves the burning, itching, and pain experienced with dermatoses such as radiation dermatitis and atopic dermatitis. It also relieves the pain of first- and second-degree burns and helps to relieve dry waxy skin by maintaining a moist wound environment, which is beneficial to the healing process. The over-the-counter product relieves the burning and itching associated with many common types of skin irritation, lacerations, abrasions, and minor burns including sunburn. For more information, visit www.intraderm.com.
Promius Promise
Promius Pharma LLC announces that the Promius Promise program has been expanded to include Cloderm (clocortolone pivalate) Cream 0.1% and Trianex (triamcinolone acetonide) Ointment 0.05%, both for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. The Promius Promise program was created in 2013 to support patients. This program features a dedicated call center staff to educate patients about their insurance coverage and answer any questions they may have about their out-of-pocket cost, co-pay assistance, and prior authorizations. For more information, visit www.promiuspharma.com.
Radiesse
Merz North America, Inc, receives US Food and Drug Administration approval of Radiesse for correction of volume loss in the dorsum of the hands. Radiesse is an opaque dermal filler composed of calcium hydroxylapatite microspheres suspended in a water-based gel carrier. It provides an immediate volumizing effect and helps reduce the prominence of tendons and veins in the hands, delivering natural-looking results that can last up to 1 year. Radiesse also is indicated for subdermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. For more information, visit www.MerzUSA.com.
If you would like your product included in Product News, please e-mail a press release to the Editorial Office at cutis@frontlinemedcom.com.
Alevicyn SG Antipruritic Spray Gel
IntraDerm Pharmaceuticals, a division of Oculus Innovative Sciences, Inc, receives 510(k) clearance from the US Food and Drug Administration for Alevicyn SG Antipruritic Spray Gel with both prescription and over-the-counter indications. The Alevicyn SG prescription product manages and relieves the burning, itching, and pain experienced with dermatoses such as radiation dermatitis and atopic dermatitis. It also relieves the pain of first- and second-degree burns and helps to relieve dry waxy skin by maintaining a moist wound environment, which is beneficial to the healing process. The over-the-counter product relieves the burning and itching associated with many common types of skin irritation, lacerations, abrasions, and minor burns including sunburn. For more information, visit www.intraderm.com.
Promius Promise
Promius Pharma LLC announces that the Promius Promise program has been expanded to include Cloderm (clocortolone pivalate) Cream 0.1% and Trianex (triamcinolone acetonide) Ointment 0.05%, both for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. The Promius Promise program was created in 2013 to support patients. This program features a dedicated call center staff to educate patients about their insurance coverage and answer any questions they may have about their out-of-pocket cost, co-pay assistance, and prior authorizations. For more information, visit www.promiuspharma.com.
Radiesse
Merz North America, Inc, receives US Food and Drug Administration approval of Radiesse for correction of volume loss in the dorsum of the hands. Radiesse is an opaque dermal filler composed of calcium hydroxylapatite microspheres suspended in a water-based gel carrier. It provides an immediate volumizing effect and helps reduce the prominence of tendons and veins in the hands, delivering natural-looking results that can last up to 1 year. Radiesse also is indicated for subdermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. For more information, visit www.MerzUSA.com.
If you would like your product included in Product News, please e-mail a press release to the Editorial Office at cutis@frontlinemedcom.com.
